<DOC>
	<DOCNO>NCT02964208</DOCNO>
	<brief_summary>The AMPLATZER LAA Occluder transcatheter , self-expanding nitinol device intend use prevent thrombus embolization LAA . The purpose study compile real world outcome data use AMPLATZER LAA Occluder subject non-valvular atrial fibrillation ( NVAF )</brief_summary>
	<brief_title>AMPLATZERâ„¢ LAA Occluder Post Approval Study ( PAS )</brief_title>
	<detailed_description>The AMPLATZER LAA Occluder device clinically evaluate post approval study . This prospective , multicenter , non-randomized observational post-approval study , patient undergo implant AMPLATZER LAA Occluder .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<criteria>18 year age older Documented history nonvalvular atrial fibrillation Subject intend implanted AMPLATZER LAA Occluder device Women childbearing potential , plan become , pregnant time study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Thromboembolism</keyword>
	<keyword>Stroke</keyword>
	<keyword>ACP</keyword>
	<keyword>Left Atrial Appendage</keyword>
	<keyword>Cardiac Plug</keyword>
</DOC>